ERBB2 and breast cancer: In this study, we showed that changes in the tumor microenvironment, using Matrigel as cell culture media, caused T-DM1 resistance of HER2-positive breast cancer cells that are otherwise sensitive to T-DM1 treatment in 2D cell culture dishes.